Sara J. Adair

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Inhibition of Focal Adhesion Kinase by PF-562,271 Inhibits the Growth and Metastasis of Pancreatic Cancer Concomitant with Altering the Tumor Microenvironment

Jayme B. Stokes, Sara J. Adair, Jill K. Slack‐Davis et al. · Molecular Cancer Therapeutics · 2011 · 238 citations · Full text

Pathology, Cancer Biology, Tumor Biology +16

Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth

Sarbajeet Nagdas, Jennifer A. Kashatus, Aldo Nascimento et al. · Cell Reports · 2019 · 142 citations · Full text

Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells

Xiaolong Wei, Jiekun Yang, Sara J. Adair et al. · Proceedings of the National Academy of Sciences · 2020 · 104 citations · Full text

Treatment of ovarian cancer cell lines with 5-aza-2′-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules

Sara J. Adair, Kevin T. Hogan · Cancer Immunology Immunotherapy · 2008 · 101 citations · Full text

Oncology, Medicine, Tumor Immunity +10